How are RVMD straddle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the RVMD straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 63.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$2,144.58 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a RVMD straddle?

The breakeven for the RVMD straddle priced on this page is roughly $122.95 and $167.05 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current RVMD market-implied 1-standard-deviation expected move is approximately 18.32%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current RVMD implied volatility affect this straddle?

RVMD ATM IV is at 63.90% with IV rank near 31.69%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

RVMD Straddle Strategy

RVMD (Revolution Medicines, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also develops RMC-5845, a selective inhibitor of SOS1, a protein that converts RAS (OFF) to RAS (ON) in cells; and RMC-5552, a hyperactivated selective inhibitor of mTORC1 signaling in tumors. In addition, the company is developing RMC-6291, a mutant-selective inhibitor of KRASG12C(ON) and NRASG12C(ON); and RMC-6236, a RAS-selective inhibitor of multiple RAS(ON) variants. Further, it develops RAS(ON) Inhibitors targeting KRASG13C(ON) and KRASG12D(ON). The company has a collaboration agreement with Sanofi for the research and development of SHP2 inhibitors, including RMC-4630.

RVMD (Revolution Medicines, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $31.88B, a beta of 1.41 versus the broader market, a 52-week range of 34-155.7, average daily share volume of 3.0M, a public-listing history dating back to 2020, approximately 616 full-time employees. These structural characteristics shape how RVMD stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.41 indicates RVMD has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a straddle on RVMD?

A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.

Current RVMD snapshot

As of May 15, 2026, spot at $145.12, ATM IV 63.90%, IV rank 31.69%, expected move 18.32%. The straddle on RVMD below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this straddle structure on RVMD specifically: RVMD IV at 63.90% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 18.32% (roughly $26.59 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated RVMD expiries trade a higher absolute premium for lower per-day decay. Position sizing on RVMD should anchor to the underlying notional of $145.12 per share and to the trader's directional view on RVMD stock.

RVMD straddle setup

The RVMD straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With RVMD near $145.12, the first option leg uses a $145.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed RVMD chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 RVMD shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$145.00	$11.15
Buy 1	Put	$145.00	$10.90

RVMD straddle risk and reward

Net Premium / Debit: -$2,205.00
Max Profit (per contract): Unbounded
Max Loss (per contract): -$2,144.58
Breakeven(s): $122.95, $167.05
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.

RVMD straddle payoff curve

Modeled P&L at expiration across a range of underlying prices for the straddle on RVMD. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	+$12,294.00
$32.10	-77.9%	+$9,085.43
$64.18	-55.8%	+$5,876.85
$96.27	-33.7%	+$2,668.28
$128.35	-11.6%	-$540.29
$160.44	+10.6%	-$661.14
$192.52	+32.7%	+$2,547.44
$224.61	+54.8%	+$5,756.01
$256.70	+76.9%	+$8,964.58
$288.78	+99.0%	+$12,173.16

When traders use straddle on RVMD

Straddles on RVMD are pure-volatility plays that profit from large moves in either direction; traders typically buy RVMD straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.

RVMD thesis for this straddle

The market-implied 1-standard-deviation range for RVMD extends from approximately $118.53 on the downside to $171.71 on the upside. A RVMD long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current RVMD IV rank near 31.69% is mid-range against its 1-year distribution, so the IV signal is neutral; the straddle thesis on RVMD should anchor more to the directional view and the expected-move geometry. As a Healthcare name, RVMD options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to RVMD-specific events.

RVMD straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. RVMD positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move RVMD alongside the broader basket even when RVMD-specific fundamentals are unchanged. Always rebuild the position from current RVMD chain quotes before placing a trade.

Frequently asked questions

What is a straddle on RVMD?: A straddle on RVMD is the straddle strategy applied to RVMD (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With RVMD stock trading near $145.12, the strikes shown on this page are snapped to the nearest listed RVMD chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are RVMD straddle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the RVMD straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 63.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$2,144.58 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a RVMD straddle?: The breakeven for the RVMD straddle priced on this page is roughly $122.95 and $167.05 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current RVMD market-implied 1-standard-deviation expected move is approximately 18.32%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a straddle on RVMD?: Straddles on RVMD are pure-volatility plays that profit from large moves in either direction; traders typically buy RVMD straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
How does current RVMD implied volatility affect this straddle?: RVMD ATM IV is at 63.90% with IV rank near 31.69%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.